Newsfeeds Archive - Page 96 of 696

1 minute read

News

“Amazon Music Unlimited Is Raising Prices For Prime Members From $8.99 To $9.99 Per Month And Family Plan Users From $15.99 To $16.99 Per Month ” – Tech Crunch

August 16, 10:23 AM

https://techcrunch.com/2023/08/16/amazon-music-unlimited-raising-prices-prime-members-family-plan/#:~:text=The%20Amazon%20Music%20Unlimited%20Individual,%24159%20to%20%24169%20per%20year. The price of Amazon Music

AMZN

4 minute read

Bristol Myers Squibb Announces Updated Data From TRIDENT-1 Trial Show Durable Efficacy Benefits With Repotrectinib For Patients With Locally Advanced Or Metastatic ROS1-Positive Non-Small Cell Lung Cancer

By Happy Mohamed

August 16, 10:20 AM

Repotrectinib continued to demonstrate high response rates and durable responses, including robust intracranial responses, in patients with ROS1-positive locally advanced or metastatic non-small cell lung cancer who

BMY

2 minute read

News

“‘Barbie’ To Arrive On Digital Next Month; Set To Arrive On Digital On Sept. 5. It’s Available To Pre-Order On Amazon For $19.99” – Variety

By Happy Mohamed

August 16, 10:15 AM

https://variety.com/2023/film/news/barbie-movie-digital-release-how-to-watch-online-1235697704/ If you purchase an independently reviewed product or service through a link on our website, Variety may receive an

AMZN

6 minute read

Astrazeneca Data At WCLC Advance Ambition To Have An Astrazeneca Medicine For More Than Half Of All Patients Treated For Lung Cancer By 2030

By Happy Mohamed

August 16, 10:09 AM

FLAURA2 data reinforce Tagrisso as backbone therapy for EGFR-mutated advanced lung cancer in combination with chemotherapy; granted Breakthrough Therapy Designation in the US. Further results for

AZN

3 minute read

Chimerix Announces Data Highlighting Clinical Efficacy And Molecular Mechanisms Of Response To ONC201 Treatment Of H3 K27M-Mutant Diffuse Midline Gliomas Published In “Cancer Discovery”

By Happy Mohamed

August 16, 10:07 AM

Patients Treated with ONC201 Demonstrated Median Overall Survival (mOS) of 21.7 Months in the Front-Line Setting, Post Radiation, Versus 12 Months mOS Historical Control ONC201 Treatment Disrupts Key Metabolic

CMRX

1 minute read

Progressive Reports July 2023 Results; EPS $1.02 Vs $1.17 YoY; Net income $604.4M Vs $688.8 YoY

By Happy Mohamed

August 16, 9:46 AM

The Progressive Corporation (NYSE:PGR) today reported the following results for July 2023: July (millions, except per share amounts and ratios; unaudited) 2023 2022 Change Net

PGR

4 minute read

News

Innoviz Reiterates Value Proposition In Open Letter To Shareholders

By Happy Mohamed

August 16, 9:31 AM

Recently Completed Public Offering Bolsters Balance Sheet TEL AVIV, Israel, Aug. 16, 2023 /PRNewswire/ -- Innoviz Technologies Ltd. (NASDAQ:INVZ) ("Innoviz"), a leading Tier-1 direct supplier of

INVZ

1 minute read

News

Performance Shipping Inc. Regains Compliance With Nasdaq Minimum Bid Price Requirement

By Happy Mohamed

August 16, 9:28 AM

Performance Shipping Inc. (NASDAQ:PSHG), ("we" or the "Company"), a global shipping company specializing in the ownership of tanker vessels, today announced that the Nasdaq Stock Market

PSHG

2 minute read

AMTD Digital Expects To Achieve Over 50% Increase In Net Profit For FY23

By Happy Mohamed

August 16, 9:19 AM

AMTD Digital Inc. ("AMTD Digital" or the "Company") (NYSE:HKD), a comprehensive one-stop digital solutions platform headquartered in France, announced today that it is expected to achieve a

AMTD

2 minute read

News

The Trū Shrimp Companies Appoints Hawkins As Exclusive U.S. Distributor For Trū Chitosan

By Happy Mohamed

August 16, 9:15 AM

The trū® Shrimp Companies, Inc. ("trū Shrimp") announced today that trū Shrimp has appointed Hawkins, Inc. ("Hawkins") (NASDAQ:HWKN) as the exclusive distributor of its

HWKN